Ardelyx Garners $30,000,000 Series B Funding

  • Feed Type
  • Date
    8/31/2011
  • Company Name
    Ardelyx
  • Mailing Address
    34175 Ardenwood Blvd. Fremont, CA 94555
  • Company Description
    The company develops therapeutics for disease treatment.
  • Website
    http://www.ardelyx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds of the financing will be used to advance Ardelyx’s pipeline that includes three product candidates: a clinical stage product, RDX5791, being evaluated in constipation-predominant irritable bowel syndrome (IBS-C) and in the prevention of excess dietary sodium absorption, and two preclinical products, RDX002 in chronic kidney disease and RDX009 in type 2 diabetes.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    CMEA Capital
  • Venture Investor
    Amgen Ventures

By posting a comment, you agree to our terms and conditions.